| #233 |
David L. Standley |
Altasens |
1 |
| #233 |
Joseph M. Onorato |
Google |
1 |
| #233 |
Roberto M. Aimi |
MIT |
1 |
| #233 |
Douglas A. Collins |
Rayvio |
1 |
| #233 |
Everest Huang |
MIT |
1 |
| #233 |
Alexander Shkolnik |
Liquidpiston |
1 |
| #233 |
Emil Jacob |
— |
1 |
| #233 |
Sokwoo Rhee |
Millennial Net |
1 |
| #233 |
Sang Bae Kim |
LG |
1 |
| #233 |
Chikao Tsuchiya |
Nissan Motor Co. |
1 |
| #233 |
Peter E. Norris |
Tomophase |
1 |
| #233 |
Jonathan Hayes |
Inmusic Brands |
1 |
| #233 |
Michael J. Hawley |
Alcatel Lucent |
1 |
| #233 |
Jin Gyu Park |
Cheil Industries |
1 |
| #233 |
Rohit N. Karnik |
MIT |
1 |
| #233 |
Thomas C. Hayes |
Varn Products Company |
1 |
| #233 |
Laura M. Hales |
Extend Biosciences |
1 |
| #233 |
Dale Porter |
Dana-Farber Cancer Institute |
1 |
| #233 |
Eric Dane |
MIT |
1 |
| #233 |
Sung-Yun Kwon |
Theraject |
1 |
| #233 |
Neil Lawrence Mayle |
Slyce Acquisition |
1 |
| #233 |
Jonathan S. Yedidia |
Mitsubishi Electric |
1 |
| #233 |
Firdaus Bhathena |
Cisco |
1 |
| #233 |
Richard C. Svrluga |
Exogenesis |
1 |
| #233 |
Edward J. Fischer |
Groove Networks |
1 |
| #233 |
Chris Reiner |
Voice Signal Technologies |
1 |
| #233 |
Alexandra Rousseau |
Boston Scientific Scimed |
1 |
| #233 |
W. Patrick Hays |
Mips Technologies |
1 |
| #233 |
Luca Dal Negro |
Boston University |
1 |
| #233 |
Sriram Kosuri |
Harvard University |
1 |
| #233 |
Manjunatha N. Ramanathpura |
Cisco |
1 |
| #233 |
Tareef Kawaf |
Art & Tech Co. |
1 |
| #233 |
Douglas A. Lauffenburger |
MIT |
1 |
| #233 |
Moe Z. Win |
AT&T |
1 |
| #233 |
Igor L. Belakovskiy |
IBM |
1 |
| #233 |
William Cullen |
Aurea Software |
1 |
| #233 |
Tzu-Yang Yu |
MIT |
1 |
| #233 |
Paul A. Blackborow |
Energetiq Technology |
1 |
| #233 |
Charles C. Able |
Tecan Trading Ag |
1 |
| #233 |
Martin Maier |
Alnylam Pharmaceuticals |
1 |
| #233 |
Jean-Luc Robert |
Koniniklijke Philips N.V. |
1 |
| #233 |
Robert J. Schwartz |
Baylor College Of Medicine |
1 |
| #233 |
Allan S. Myerson |
Metals Recycling Technologies |
1 |
| #233 |
Seth Lloyd |
Stanford University |
1 |
| #233 |
Justin Andrew Caravella |
Forma Therapeutics |
1 |
| #233 |
David J. Mooney |
Harvard University |
1 |
| #233 |
Xiaoyun Wu |
The Broad Institute |
1 |
| #233 |
Vasant Jadhav |
Alnylam Pharmaceuticals |
1 |
| #233 |
Keng Hui Lim |
MIT |
1 |
| #233 |
Richard Mansfield |
Fortelligent |
1 |